Incorporated in 1939, Godavari Biorefineries Ltd (GBL) is a manufacturer of bio-based chemicals and ethanol, standing as one of India's pioneering integrated bio-refinery companies. GBL is a part of the Somaiya group, which holds a significant 63.31% equity stake in the company through various entities, making it a well-established player in the renewable chemicals and biofuels sector.
The company operates as an integrated bio-refinery in India with an installed capacity of 570 KLPD for manufacturing ethanol and has established itself as a key manufacturer in the bio-based chemical space. The company also has an in-house retail brand, Jivana, for the sale of sugar, turmeric, and salt in Rajasthan, Maharashtra, Karnataka, and Gujarat.
Godavari Biorefineries operates across multiple segments within the bio-refinery value chain, including Sugar, Branded Sugar, Ethanol, Bio-Based Chemicals, and Power. The company has achieved several industry-firsts, including India's first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility, and is recognized as the largest manufacturer of MPO in India in terms of installed capacity.
The company's chemical portfolio is extensive, offering chemicals such as bio-based acetic acid, bio-based ethyl acetate, bio-based butanol, 1,3 butylene glycol, and various perfumery and pharmaceutical grade alcohols. Additionally, the company provides hand sanitizers and sugarcane wax, and produces electricity through the generation of steam and power from biomass.
As of July 2025, the market capitalization of Godavari Biorefineries Ltd (GODAVARIB) is ₹1,353.55 Crore. The stock has experienced significant volatility, with a 52-week high of ₹408.60 and a 52-week low of ₹145.
The company reported mixed financial results for FY 2025. Sales rose 10.88% to ₹1,870.25 crore in the year ended March 2025, compared to ₹1,686.67 crore in the previous year. However, the company faced profitability challenges, reporting a net loss of ₹23.41 crore in FY 2025, as against a net profit of ₹12.30 crore in FY 2024.
For the quarter ended March 2025, the company showed resilience in profitability, with net profit rising 10.37% to ₹71.93 crore, compared to ₹65.17 crore in the previous corresponding quarter. However, sales declined 5.80% to ₹579.50 crore in Q4 FY25, against ₹615.19 crore in Q4 FY24.
• Revenue FY 2025: ₹1,870.25 crore
• Net Loss FY 2025: ₹23.41 crore
• Q4 FY25 Revenue: ₹579.50 crore
• Q4 FY25 Net Profit: ₹71.93 crore
• P/E Ratio: -57.77 (as of July 2025)
• P/B Ratio: 2.70 (as of July 2025)
• Market Capitalization: ₹1,353.55 crore (as of July 2025)
• Promoter Holding: 63.31% (Somaiya Group)
The company is pursuing several strategic initiatives to strengthen its market position. The restoration of the ethanol blending program using sugarcane juice enabled better utilization of ethanol capacity during the crushing season. Looking ahead, the 200 KLPD grain/maize distillery is progressing as planned and is expected to be commissioned in Q4 FY26.
Godavari Biorefineries has made significant strides in research and development, particularly in the healthcare sector. The company announced that its European patent for a novel anti-cancer molecule has been validated in Spain, the United Kingdom, and as a Unitary Patent covering multiple EU member states. This milestone underscores the company's growing presence in high-impact scientific innovation, led by its dedicated Anti-Cancer Research Segment.
The patented molecule has shown promising results, with potential in the treatment of various cancers, including breast and prostate cancer, demonstrating encouraging efficacy and safety profiles in preclinical animal studies. The molecule is currently in Phase 1a clinical trials to assess safety in human patients with advanced solid tumors as well as in healthy volunteers.
The company has established robust manufacturing capabilities across its facilities. It achieved a record cane crushing of 24.65 lakh tonnes for the sugar season 2024-25 at its Sameerwadi facility. The Sameerwadi Manufacturing Plant operates with a crushing capacity of 18,000 TCD.
Godavari Biorefineries serves a diverse customer base across various industries. Its marquee customers include Hershey India Pvt Ltd, Hindustan Coca-Cola Beverages Private Limited, M/s Karnataka Chemical Industries, LANXESS India Private Limited, IFF Inc., and major Oil Marketing Companies.
The company is led by Chairman & Managing Director Mr. Samir Shantilal Somaiya, who has been instrumental in guiding the company's strategic direction and growth initiatives.
Godavari Biorefineries Limited represents a significant player in India's bio-refinery sector, with its integrated approach to manufacturing ethanol, bio-based chemicals, and sugar products. While the company faces challenges in terms of profitability and market volatility, its strategic initiatives in expanding production capacity, diversifying feedstock options, and investing in innovative research areas like cancer therapeutics position it for potential long-term growth in the evolving renewable chemicals and biofuels market.
